ENERGI‑F703EB Cream
Diabetic Foot Ulcer
Phase 2Active
Key Facts
About Energenesis Biomedical
Taiwanese biotech advancing small‑molecule topical therapies for diabetic wound healing.
View full company profileTherapeutic Areas
Other Diabetic Foot Ulcer Drugs
| Drug | Company | Phase |
|---|---|---|
| Woxheal | Centaur Pharmaceuticals | Phase 3 |
| Stempeucel® | Stempeutics Research | Phase 3 |
| C2C_ASC | Cell2Cure | Phase 1/2 |
| ON101 (FESPIXON®) | Oneness Biotech | Phase 3 |